Th1/Th2 balance: An important indicator of efficacy for intra-arterial chemotherapy

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 6, 2008, Pages 959-963

  Nagai, Hidenari ^a   Miyaki, Daisuke ^a   Matsui, Teppei ^a   Kanayama, Masahiro ^a   Higami, Katsuya ^a   Momiyama, Kouichi ^a   Ikehara, Takashi ^a   Watanabe, Manabu ^a   Sumino, Yasukiyo ^a   Miki, Kazumasa ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Advanced HCC; Cytokine; Intra arterial chemotherapy; Liver cirrhosis; Th1 Th2 balance

Indexed keywords

CD4 ANTIGEN; CISPLATIN; CYTOKINE; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; JAPANESE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; TUMOR IMMUNITY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DRUG MONITORING; FEMALE; FLUOROURACIL; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTERFERON-GAMMA; INTERLEUKIN-4; LEUCOVORIN; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

EID: 51849150064     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0685-y     Document Type: Article

References (32)

1. K Okuda T Ohtsuki H Obata M Tomimatsu N Okazaki H Hasegawa Y Nakajima K Onishi 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928
2. N Nagasue H Yukaya T Hamada S Hirosue R Kanashima K Inokuchi 1984 The natural history of hepatocellular carcinoma. A study of 100 untreated cases Cancer 54 1461 1465
3. H Toyoda S Nakano T Kumada I Takeda K Sugiyama T Osada S Kirishima T Suga M Takahashi 1995 The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma Oncology 52 295 299
4. K Murata K Shiraki T Kawakita N Yamamoto H Okano M Nakamura Sakai Takahisa M Deguchi S Ohmori T Nakano 2003 Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma Anticancer Res 23 1719 1722
5. K Okuda M Tanaka J Shibata E Ando T Ogata H Kinoshita N Eriguchi S Aoyagi K Takikawa 1999 Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment Oncol Rep 6 587 591
6. H Nagai T Matsui M Kanayama K Momiyama A Ikoma N Okano T Ikehara K Matsumaru M Watanabe K Iida K Ishii Y Sumino K Miki 2007 Assessment of combined intra-arterial low-dose 5-fluorouracil, cisplatin, and leucovolin chemotherapy for patients with advanced hepatocellular carcinoma using the Japan integrated staging score J Med Soc Toho 54 21 28
7. H Nagai M Kanayama K Higami K Momiyama A Ikoma N Okano K Matsumaru M Watanabe K Ishii Y Sumino K Miki 2007 Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma World J Gastroenterol 13 2 280 284
8. + suppressor T cell J Exp Med 193 F41 F46
9. LA Stephens C Mottet D Mason F Powrie 2001 Human CD4+ CD25+ thymoctes and peripheral T cells have immune suppressive activity in vitro Eur J Immunol 31 1247 1254
10. H Jonuleit E Schmitt M Stassen A Tuettenberg J Knop AH Enk 2001 Identification and functional characterization of human CD4+ CD25+ T cells with regulatory properties isolated from peripheral blood J Exp Med 193 1285 1294
11. TR Mosmann RL Coffman 1989 Th1 and Th2 cells: different patterns of lymphokine secretion lead to different funtional properties Annu Rev Immunol 7 145 173
12. A O'Garra 1998 Cytokines induce the development of funtionally heterogenous T helper cell subsets Immunity 8 275 283
13. Roitt I (ed) (1997) Essential immunology, 9th edn. Blackwell, Malden, MA
14. Kuby J, Cameron J, Todd C, Mitchell J (2000) Immunology. 4th edn. Freeman Company, New York
15. M Kobayashi H Kobayashi RB Pollard F Suzuki 1998 A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma J Immunol 160 5869 5873
16. L Zitvogel JI Mayordomo T Tjandrawan AB DeLeo MR Clarke MT Lotze WJ Storkus 1996 Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J Exp Med 183 87 97
17. K Tsung JB Meko GR Peplinski YL Tsung JA Norton 1997 IL-12 induces T helper 1-directed antitumor response J Immunol 158 3359 3365
18. GJ Weiner HM Liu JE Wooldridge CE Dahle AM Krieg 1997 Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization Proc Natl Acad Sci USA 94 10833 10837
19. H-M Hu WJ Urba BA Fox 1998 Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from Type 2 to a type 1 cytokine profile J Immunol 161 3033
20. T Iwamiya S Sawada Y Ohta 1994 Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system Cancer Chemother. Pharmacol 33 Suppl. S134 S138
21. M Shinohara K Ishii N Takamura 2003 Long-term changes of peripheral blood CD4-positive T cell subsets (Th1, Th2) in chronic hepatitis C patients with a sustained response no response to IFN Hepatol Res 27 260 265
22. T Jung U Schauer C Heusser C Neumann C Rieger 1993 Detection of intracellular cytokines by flow cytometry J Immunol Methods 159 197 207
23. M Kudo H Chung Y Osaki 2003 Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for new staging system, the Japan Integrated Staging score (JIS score) J Gastroenterol 38 207 215
24. N Takamura K Ishii M Shinohara T Kawafune Y Sumino 2002 Analysis of peripheral blood CD4 positive T cells using intracellular staging method in patients with chronic hepatitis C J Med Soc Toho Univ 49 45 52
25. K Ishii N Takamura M Shinohara H Shin T Ikehara S Hata T Kawafune Y Sumino Y Ohmoto 2002 Intracellular cytokine analysis of CD4-positive T cells predictive of sustained response to interferon therapy for patients with chronic hepatitis C Dig Dis Sci 47 778 783
26. K Fukuzawa K Takahashi K Furuta T Tagaya T Ishikawa K Wada Y Omoto T Koji S Kakumu 2001 Expression of Fas/Fas ligand and its involvement in infiltrating lymphocytes in hepatocellular carcinoma J Gastroenterol 36 681 688
27. E Yakirevich O Lefel Y Sova A Stein O Cohen OB Izhak MB Resnick 2002 Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma J Pathol 196 67 75
28. M Ikeguchi K Oi Y Hirooka N Kaibara 2004 CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma Eur J Surg Oncol 30 53 57
29. S Sakaguchi 2004 Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 531 562
30. E Unitt SM Rushbrook A Marshall S Davies P Gibbs LS Morris N Coleman GJ Alexander 2005 Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells Hepatology 41 722 730
31. LA Ormandy T Hillemann H Wedemeyer MP Manns TF Greten F Korangy 2005 Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 2457 2464
32. XH Yang S Yamagiwa T Ichida Y Matsuda S Sugahara H Watanabe Y Sato T Abo DA Horwitz Y Aoyagi 2006 Increase of CD4+ CD25+ regulatory T cells in the liver of patients with hepatocellular carcinoma J Hepatol 45 254 262